naveta.featured

naveta.title

naveta.description

naveta.visit

naveta.objectives

  • naveta.obj1
  • naveta.obj2
  • naveta.obj3
  • naveta.obj4
  • naveta.obj5

naveta.areas

  • Psoriasis / Atopic dermatitis
  • HIV pharmaceutical care
  • Inflammatory bowel disease
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Migraine
  • Ophthalmology (DME, AMD)
  • Obesity
  • Oncology

naveta.awards

SEFH Innovation Award 2021 - Best telepharmacy innovation project

AMPHOS Pharmacy Award 2022 - Best hospital pharmacy management experience

FarmaImpulso OH Oncología 2024 - Innovative project award (ALGOPROMIA)

FarmaImpulso IMIDs 2024 - ML for quality of life prediction in rheumatoid arthritis

SEFH/CSL Vifor 1st Prize 2025 - Quality of Pharmacy Services (ZAFIRO, derived from NAVETA)

Creasphere Spain by Roche 2024 - Digital health startup programme grant

Visionarium Innovation by Gilead 2025 - IA-PROM-VIH, AI-based PROMs analysis for HIV

naveta.keyPubs

Implementing Systematic Patient-Reported Measures Through the Naveta Value-Based Telemedicine Initiative

JMIR Mhealth Uhealth. 2024;12:e56196

Person-centred coordinated care experience measured by the P3CEQ

Health Serv Insights. 2024;13:11786329241258856

TELEPROM Psoriasis: Enhancing patient-centered care and HRQoL

Front Med (Lausanne). 2024;11:1465725

Developing a Prototype Machine Learning Model to Predict QoL in People Living With HIV

Integr Pharm Res Pract. 2025;14:1-16